appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Sandu Pharmaceuticals Ltd
SANDUPHQ
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Sandu Pharmaceuticals is engaged in manufacturing and marketing of ayurvedic medicine
PeersCompare with peers
Godrej Consumer Products Ltd
Dabur India Ltd
Marico Ltd
Colgate-Palmolive (India) Ltd
Procter & Gamble Hygiene and Health Care Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Company Update
SANDU PHARMACEUTICALS LTD. - 524703 - Announcement Under Regulation 30 Order To Drop Proceeding In Respect Of Return After Scrutiny For The Financial Year 2020-2021 Under Section 61 Of CGST Act . | Download
SANDU PHARMACEUTICALS LTD. - 524703 - Announcement Under Regulation 30 Order To Drop Proceeding In Respect Of Return After Scrutiny For The Financial Year 2020-2021 Under Section 61 Of CGST Act . | Download
Company Update
SANDU PHARMACEUTICALS LTD. - 524703 - Corrigendum To The Unaudited Financial Results Of The Company For The Period Ended On September 30, 2024. | Download
SANDU PHARMACEUTICALS LTD. - 524703 - Corrigendum To The Unaudited Financial Results Of The Company For The Period Ended On September 30, 2024. | Download
Cash Dividend
Final • Div/Share: ₹ 0.8
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant